Teleradiology Solutions

telradsol.com

-76%

est. 2Y upside i

Series A

Rank

#2830

Sector

Teleradiology Services

Est. Liquidity

~3Y

Data Quality

Data: Medium

Teleradiology Solutions operates in a rapidly growing market ($60.2B TAM, ~25% YoY growth) driven by radiologist shortages and increasing demand for remote diagnostics.

Last updated: March 10, 2026

Bull (15%)+350%

Teleradiology Solutions successfully integrates advanced AI into its RADSpa® platform, significantly improving diagnostic efficiency and accuracy, and expands its global footprint into underserved markets. This drives revenue to $70M+ by 2028, justifying a $425M+ valuation (6x revenue) and providing substantial returns for common equity holders after preference stack.

Base (35%)+50%

The company maintains its market position, growing steadily at 20-25% annually by securing new contracts and leveraging its global network. Revenue reaches approximately $25M by 2028, leading to an estimated valuation of $140M (5.6x revenue), offering a moderate return for common shareholders given the preference stack.

Bear (50%)-80%

Intense competition from well-funded incumbents and rapidly evolving AI solutions from tech giants erode market share and pricing power. Growth slows significantly, and the company struggles to raise subsequent funding at a higher valuation. An exit at or below the estimated $95M valuation, or even a down round, results in minimal to no returns for common equity holders due to the $46M liquidation preference.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Investors hold approximately $46 million in liquidation preferences, meaning common shareholders may receive little or nothing in an exit at or below this amount.

Dilution Risk

high

As a Series A company, Teleradiology Solutions will likely require additional funding rounds to achieve scale, which will dilute existing common equity holders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Teleradiology Solutions' shares at this stage.

Questions to Ask at the Interview

Strategic questions based on Teleradiology Solutions's data — designed to show you've done your homework.

  • 1

    Given the rapid advancements in AI and the active involvement of major players like RadNet and Siemens Healthineers in teleradiology, how is Teleradiology Solutions planning to evolve its proprietary RADSpa® platform and service offerings to maintain its competitive moat and differentiate from these powerful incumbents?

  • 2

    With a current revenue of $14M in a $60.2B TAM, what are the specific growth strategies for the next 2-3 years, particularly regarding market expansion, new service lines, or deeper penetration into existing contracts, and how do these plans address the relatively low gross margin of ~20%?

  • 3

    Considering the Series A funding in 2020 and the significant preference stack from $46M in total funding, what is the company's anticipated timeline and strategy for a liquidity event, and how does the leadership team envision creating meaningful value for common equity holders?

Community

Valuation Sentiment

Our model estimates -76% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.